Disclosures / Herzberg, Dr. Max
T9G
Vidac Pharma Holding PLC
Amount
€14K
@ €0.57 / per share
Detailed Analysis
Dr. Max Herzberg, a management board member at Vidac Pharma Holding PLC, sold €14,000 worth of shares at €0.57 per share on April 28, 2026. This open-market sale carries minimal analytical significance as such transactions reflect routine portfolio management rather than material confidence signals. The modest transaction size and standard 6-day disclosure delay provide no actionable insights regarding company fundamentals.
Price history — T9G
Price since trade
—
SPY since trade
—
No price data available
Trade date
28 April 2026
When the trade occurred
Disclosed date
04 May 2026
6-day delay
Disclosure delay: 6 days. This trade was reported to regulators 6 days after it occurred. By the time this filing became public, markets had 6 additional days to react to any non-public information.
Reference data
Use these identifiers to look up this instrument in your own platform. Disclosyr does not link to any broker.
Ticker
T9G
ISIN
GB00BM9XQ619
Exchange
XETR
Company
Vidac Pharma Holding PLC
Filed with bafin germany on 04 May 2026